| 期刊論文| 1. | Boozer, C. N.、Nasser, J. A.、Heymsfield, S. B.、Wang, V.、Chen, G.、Solomon, J. L.(2001)。An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial。International Journal of Obesity and Related Metabolic Disorders，25(3)，316-324。   | | 2. | Alan, S. H.、Gregory, L. K.(2003)。American Society for Clinical Pharmacology and Therapeutics position statement on the public health risks of ephedra。Clinical Pharmacology and Therapeutics，74(5)，403-405。 | | 3. | Bell, D. G.、Jacobs, I.、Ellerington, K.(2001)。Effect of caffeine and ephedrine ingestion on anaerobic exercise performance。Medicine and Science in Sports and Exercise，33(8)，1399-1403。 | | 4. | Bell, D. G.、McLellan, T. M.、Sabiston, C. M.(2002)。Effect of ingesting caffeine and ephedrine on 10-km run performance。Medicine and Science in Sports and Exercise，34(2)，344-349。 | | 5. | Bent, S.、Tiedt, T. N.、Shlipak, M. G.(2003)。The relative safety of ephedra compared with other herbal products。Annals of Internal Medicine，138(6)，468-471。 | | 6. | Donald, M. M.、Arthur, P. G.、Sidney, M. W.(2003)。Still lots of danger in ephedra-free products。Science，301，1669-1671。 | | 7. | Consumers Unions(2003)。Working to get ephedra banned。Consumer Reports，68，6。 | | 8. | Catlin, D. H.、Murray, T. H.(1996)。Performance-enhancing drugs, fair competition, and Olympic sport。Journal of the American Medical Association，276(3)，231-237。 | | 9. | Catlin, D. H.、Hatton, C. K.(1991)。Use and abuse of anabolic and other drugs for athletic enhancement。Advances in Internal Medicine，36，399-424。 | | 10. | Haller, C. A.、Benowitz, N. L.(2000)。Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids。The New England Journal of Medicine，343(25)，1833-1838。 | | 11. | Gurley, B. J.、Gardner, S. F.、White, L. M.、Wang, P. L.(1998)。Ephedrine pharmacokinetics after the ingestion of nutritional supplements containing ephedra sinica (Ma huang)。Therapeutic Drag Monitoring，20(4)，439-445。 | | 12. | Food and Drug Administration, HHS(2004)。Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk: Final rule。Federal Register，69(28)，6787-854。 | | 13. | Jacobs, I.、Pasternak, H.、Bell, D. G.(2003)。Effects of ephedrine caffeine, and their combination on muscular endurance。Medicine and Science in Sports and Exercise，35(6)，987-94。 | | 14. | Juhn, M.(2003)。Popular sports supplements and ergogenic AIDS。Sports Medicine，33(12)，921-939。 | | 15. | Kanayama, G.、Gruber, A. J.、Pope, H. G., Jr.、Borowiecki, J. J.、Hudson, J. I.(2001)。Over-the-counter drug use in gymnasiums: An underrecognized substance abuse problem?。Psychotherapy and Psychosomatics，70(3)，137-140。 | | 16. | Molnar, D、Torok, K.、Erhardt, E.、Jeges, S.(2000)。Safety and efficacy of treatment with an ephedrine/caffeine mixture: The first double-blind placebo-controlled pilot study in adolescents。International Journal of Obesity and Related Metabolic Disorders，24(12)，1573-1578。 | | 17. | Pipe, A.(2004)。Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance。Clinical Journal of Sport Medicine，14(3)，188-189。 | | 18. | Shekelle, P. G.、Hardy, M. L.、Morton, S. C.、Maglione, M.、Mojica, W, A.、Suttorp, M. J.、Rhodes, S. L.、Jungvig, L.、Gagne, J.(2003)。Efficacy and safety data of ephedra and ephedrine for weight loss and athletic performance。Journal of the American Medical Association，289(12)，1537-1545。 | | 19. | Samenuk, D.、Link, M. S.、Homoud, M. K.、Contreras, R.、Theoharides, C.、Wang, P. J.、Estes, N. A.、Theohardes, T. C.(2002)。Adverse cardiovascular events temporally associated with Ma Huang, an herbal source of ephedrine。Mayo Clink Proceedings，77(1)，12-16。 | 圖書| 1. | IOC(2003)。Olympic movement anti-doping code。 | | 2. | WADA(2004)。World anti-doping code。 | 其他| 1. | Ephedra Education Council(2003)。Ephedra labeling supported by science-A ben is not, industry tells FDA statement cites experts medical and scientific opinions on safety, benefits, and no need for ban of ephedra，http://www.ephedrafacts.com/whatsnew04082003.html。 | |